BEDFORD, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, announced ...
Bristol Myers Squibb has agreed to buy privately held biotechnology company Orbital Therapeutics for $1.5 billion in cash in a deal that bolsters the drugmaker's cell-therapy portfolio. Bristol Myers ...
Acquisition includes OTX-201, an investigational next-generation CAR T-cell therapy designed to reprogram cells in vivo with potential best-in-class profile for autoimmune diseases Transaction further ...
Eight years after Novartis AG gained U.S. FDA approval of the first CAR T therapy, Kymriah (tisagenlecleucel), for B-cell acute lymphoblastic leukemia, developers are advancing prospects that could ...
IoCDB Share project repository, a CTI platform that collects data from VirusTotal, AlienVault OTX, PolySwarm and AbuseIPDB APIs for hashes, domains and IPs. AegisFlow is a threat-aware CI/CD pipeline ...
Over the past decade, research and medical institutions have developed numerous apps that have helped patients living with serious health issues. From something as simple as logging sugar intake and ...
A mobile phone app designed to deliver suicide-specific therapy reduced suicidal behavior among high-risk psychiatric inpatients, according to a new study by scientists at Yale School of Medicine and ...
OTX Boxing Atlanta delivered a spectacular return to the city as OTX 15 electrified The Tabernacle on July 25. This highly anticipated event wasn’t just another night of fights; it was a demonstration ...
Atlanta, GA (July 1, 2025) Overtime Boxing (OTX), The Platform for the Next Generation of Boxers, returns to Atlanta, GA on Friday, July 25 with a stellar eight-fight card at Tabernacle headlined by a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback